Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $50.29 Analyst target: $59.73 Upside: 18.77%
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.